Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CNTX .65. Just needs to squeeze back over the $.
CNTX chart
(1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.
5606 A $0.8742 (
https://ih.advfn.com/stock-market/NASDAQ/context-therapeutics-CNTX/stock-news/90223425/statement-of-changes-in-beneficial-ownership-4
This is my plan as well.
Still an open gap down to .70 though. Anything can happen. Especially if they can get the momentum that leads to regaining compliance.
CNTX daily
Thank you for all your DD. I can't believe someone would go to such lengths to deceive me.
I dug even deeper... The merger between Stemline & BERLIN-CHEMIE AG making them a subsidiary along with Context already in the mix making up part of the MENARINI Group was done back in 2020. Totally legit.
I would go on to say the only thing CNTX needs to do is get back in compliance with their listing requirements. Which, to me, looks completely possible. And SOON.
https://finance.yahoo.com/news/context-therapeutics-clinical-partner-stemline-123000936.html
https://www.sec.gov/Archives/edgar/data/1810515/000110465920071780/tm2021445d10_ex99a5e.htm
https://www.sec.gov/Archives/edgar/data/1810515/000110465920071780/tm2021445d10_sctota.htm
https://www.sec.gov/Archives/edgar/data/1264587/000110465920071879/tm2021445d15_s8pos.htm
There's more but I'm satisfied. There's still quite the gap to fill but it can save it for a rainy day. My alerts are set.
Now I'm wondering if my email is hacked. I received a notice from etrade yesterday that CNTX filed bankruptcy along with 8 pages of copies and now today I received a BK alert on another one of my stocks - seems fishy - especially since nobody else seems to know about it.
pipeline is strong and their cashflow is strong. 40M cash doesn't come close to what you're posting.
My search didn't come up with anything. I see merge potential if anything else.
file bk??????
$$$CNTX$$$ Very interesting start. Back in. $$$
but can you read a piece of news...??? the drug is not from CNTX but from a subsidiary of Menarini.
The approved drug is in use in a phase 1 trial with a CNTX drug. There was no approval here.
The CEO was good at giving resonance to a piece of news that with CNTX marginally centered ... it was a good time to sell for those who had entered at 0.7 - 0.8 a good profit ..... there is no concrete here nothing
Exactly. Gap and trap and new bagholders. Pick your stop loss price and stick to it. Thinking this will see an offering by Friday.
But that's just my WAG.
If this is the best it can do on great news, that means tomorrow it will be bellow a dollar, that's all she wrote.
I loaded 1.10. As much as I hate gaps this is solid news.
#unreal
hoe much you leave on that table $27
Message in reply to:
just finished MSGM now I'm here $$$$$
Had to load the dip. With such real good news I believe it has every chance to go into compliance. It is also nice to see the high of day broke the premarket high.
look how big money traded MSGM. Maybe that's where most of FOMO went...lol
I'm sick of this corrupt market, that Halt managed to break the trend.
$CNTX:
this should be trading above $3 already.
buyers have to overwhelm the shorts.
story is too damn big.
who cares about charts with news like this ?
This should be above $2 by now, but somehow it's going backwards.
https://stockcharts.com/h-sc/ui?s=cntx&p=D&yr=0&mn=6&dy=0&id=p38090673899
https://www.barchart.com/stocks/quotes/cntx/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100
https://www.barchart.com/stocks/quotes/cntx/opinion
Open gap @ $.70 needs to close!
$CNTX:
very small float considering the significant institutional ownership.
this can fly to $5 with this massive development:
Context Therapeutics' Clinical Partner Stemline Therapeutics, a Subsidiary of Menarini Group Receives FDA Approval of ORSERDU(TM) (elacestrant) in ER+, HER2-, ESR1-mutated Breast Cancer
7:30 am ET January 31, 2023 (Globe Newswire)
Float 16 Mil, Market Cap 10 Mil, held by institutions 32%, 6% short, time to see the rainbow. $CNTX.
More that twice the float has been traded already. $CNTX
$CNTX:
you got that right bro.
this is beyond huge:
GlobeNewswireJanuary 31, 2023
First endocrine innovation in more than 20 years which has shown improved efficacy over standard-of-care treatments in patients with advanced breast cancer
FDA approval is in hand.
this is going to blow up sky high.
i am grabbing a few more.
CNTX: Incredible NEWS today, Herc!! (Breast Cancer one of the WORST diseases on this Planet, as we all know.)
Hey thats my old company I worked with!! Lenox Gltua peace stok
$CNTX:
Context Therapeutics' Clinical Partner Stemline Therapeutics, a Subsidiary of Menarini Group Receives FDA Approval of ORSERDU(TM) (elacestrant) in ER+, HER2-, ESR1-mutated Breast Cancer
7:30 am ET January 31, 2023 (Globe Newswire) Print
GlobeNewswireJanuary 31, 2023
First endocrine innovation in more than 20 years which has shown improved efficacy over standard-of-care treatments in patients with advanced breast cancer
ugh hope the breakfast was really good
but how much did it cost ya
wow that one is still going
@m@zing
Yes I have two of them..lol.... both healthy, no lumps
maybe it was the .09...No more eating and Trading...Just looked at the canceled order it was .09 not .90 OMG
I didn't get fill @.09...this is fucking Ridiculous NOT ONE SHARE!!!!
NICE I BOUGHT .92Z
FDA APPROVAL AGAINST BREAST CANCER, $$$$$$$$$
I'm calling a dip buy @ market open on CNTX , since I was late ...Hope that's better, eating breakfast Syrup on my keys....lol
Followers
|
10
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
98
|
Created
|
10/20/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |